4//SEC Filing
Ryali Sriram 4
Accession 0001567619-21-014218
CIK 0001305253other
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 4:26 PM ET
Size
5.4 KB
Accession
0001567619-21-014218
Insider Transaction Report
Form 4
Ryali Sriram
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-07-29+30,000→ 30,000 totalExercise: $8.15Exp: 2031-07-28→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments over 36 months measured from July 29, 2021 subject to Reporting Person's continuous service status as of each such date.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001762893
Filing Metadata
- Form type
- 4
- Filed
- Jul 29, 8:00 PM ET
- Accepted
- Jul 30, 4:26 PM ET
- Size
- 5.4 KB